Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.
Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R.
Lancet Neurol. 2011 Jan;10(1):63-74. doi: 10.1016/S1474-4422(10)70253-2.
Contemporary advances in anti-NMDAR antibody (Ab)-mediated encephalitis.
Seery N, Butzkueven H, O'Brien TJ, Monif M.
Autoimmun Rev. 2022 Apr;21(4):103057. doi: 10.1016/j.autrev.2022.103057. Epub 2022 Jan 31.
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.
Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez-Hernandez E, Aguilar E, Gresa-Arribas N, Ryan-Florance N, Torrents A, Saiz A, Rosenfeld MR, Balice-Gordon R, Graus F, Dalmau J.
Lancet Neurol. 2013 Feb;12(2):157-65. doi: 10.1016/S1474-4422(12)70310-1. Epub 2013 Jan 3.
Structural and functional mechanisms of anti-NMDAR autoimmune encephalitis.
Michalski K, Abdulla T, Kleeman S, Schmidl L, Gómez R, Simorowski N, Vallese F, Prüss H, Heckmann M, Geis C, Furukawa H.
Nat Struct Mol Biol. 2024 Dec;31(12):1975-1986. doi: 10.1038/s41594-024-01386-4. Epub 2024 Sep 3.
Parvalbumin neurons mediate neurological phenotypes of anti-NMDAR encephalitis.
Feng YF, Zeng ZK, Ni Y, Hu Y, Yang KX, Cai F, Zhou QM, Chen M, Zhu XN, Chen S, Hu J.
Brain. 2025 May 13;148(5):1652-1664. doi: 10.1093/brain/awae374.
State of the Art: Acute Encephalitis.
Bloch KC, Glaser C, Gaston D, Venkatesan A.
Clin Infect Dis. 2023 Sep 11;77(5):e14-e33. doi: 10.1093/cid/ciad306.
Anti-NMDAR Encephalitis in the Netherlands, Focusing on Late-Onset Patients and Antibody Test Accuracy.
Bastiaansen AEM, de Bruijn MAAM, Schuller SL, Martinez-Hernandez E, Brenner J, Paunovic M, Crijnen YS, Mulder MJHL, Schreurs MWJ, de Graaff E, Smitt PAE, Neuteboom RF, de Vries JM, Titulaer MJ.
Neurol Neuroimmunol Neuroinflamm. 2021 Dec 22;9(2):e1127. doi: 10.1212/NXI.0000000000001127. Print 2022 Mar.
Autoimmune Encephalitis.
Guasp M, Dalmau J.
Med Clin North Am. 2025 Mar;109(2):443-461. doi: 10.1016/j.mcna.2024.09.001. Epub 2025 Jan 2.
Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis: A Meta-analysis.
Nosadini M, Eyre M, Molteni E, Thomas T, Irani SR, Dalmau J, Dale RC, Lim M; International NMDAR Antibody Encephalitis Consensus Group; Anlar B, Armangue T, Benseler S, Cellucci T, Deiva K, Gallentine W, Gombolay G, Gorman MP, Hacohen Y, Jiang Y, Lim BC, Muscal E, Ndondo A, Neuteboom R, Rostásy K, Sakuma H, Sartori S, Sharma S, Tenembaum SN, Van Mater HA, Wells E, Wickstrom R, Yeshokumar AK.
JAMA Neurol. 2021 Nov 1;78(11):1333-1344. doi: 10.1001/jamaneurol.2021.3188.
Chimeric autoantibody receptor T cells deplete NMDA receptor-specific B cells.
Reincke SM, von Wardenburg N, Homeyer MA, Kornau HC, Spagni G, Li LY, Kreye J, Sánchez-Sendín E, Blumenau S, Stappert D, Radbruch H, Hauser AE, Künkele A, Edes I, Schmitz D, Prüss H.
Cell. 2023 Nov 9;186(23):5084-5097.e18. doi: 10.1016/j.cell.2023.10.001. Epub 2023 Nov 1.
